Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis

Company Overview

Cambridge Nutritional Sciences plc, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. Cambridge Nutritional Sciences plc operates in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc was founded in 1987 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 2.74 to 2.85
• 50-Day Range: 2.73 to 3.55
• 52-Week Range: 2.30 to 4.48
• Volume: 9,232 shs
• Average Volume: 506,313 shs
• Market Capitalization: £6.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNSL Stock Analysis - Frequently Asked Questions

How have CNSL shares performed this year?

Cambridge Nutritional Sciences' stock was trading at GBX 2.40 at the beginning of 2024. Since then, CNSL stock has increased by 14.1% and is now trading at GBX 2.74.
View the best growth stocks for 2024 here.

How do I buy shares of Cambridge Nutritional Sciences?

Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Communication
• Current Symbol: LON:CNSL
• CUSIP: N/A
• CIK: N/A
• Web: www.cnsplc.com
• Phone: (217) 235-3311
• Fax: N/A
• Employees: 3,200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 74.30
• P/E Growth: N/A
• Net Income: £-3,030,000.00
• Net Margins: -3.36%
• Pretax Margin: N/A
• Return on Equity: -3.34%
• Return on Assets: -2.36%

Debt

• Debt-to-Equity Ratio: 1.53
• Current Ratio: 4.67
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £9.77 million
• Price / Sales: 0.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 4 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 237,950,000
• Free Float: N/A
• Market Cap: £6.52 million
• Optionable: N/A
• Beta: 3.89